The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 104 participants.

Also called NCT06311019

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 104 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06311019
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06311019. Randomized; no masking; primary purpose treatment. Start 2024-02-27 (actual); primary completion 2025-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections
Acronym
Dia2tech
Condition
Type 2 Diabetes Treated With Insulin
Intervention (Device)
Continuous glucose monitoring and use of connected insulinpen for bolus insulin
Lead sponsor
Klavs Würgler Hansen (class: other)
Collaborator
Aarhus University Hospital (class: other)

Record details

Record id
cardio:ct-nct06311019
Content hash
19885529f7afd0dda23dc5ed8eb46472d9116a1a4c2ed4382febf894d715037a